Single-Rod Contraceptive Implant (Etonogestrel) Has the Lowest Typical-Use Failure Rate
The single-rod contraceptive implant has the lowest typical-use failure rate of all reversible contraceptive methods at 0.05% in the first year, making it the most effective birth control option available. 1
Contraceptive Efficacy Rankings
When comparing typical-use failure rates (which reflect real-world effectiveness including varying adherence), contraceptive methods rank as follows:
Most Effective Methods (Failure Rate <1%)
- Single-rod contraceptive implant: 0.05% - This is the clear winner for lowest failure rate 1
- Levonorgestrel IUD: 0.2% 1
- Copper IUD: 0.8% 1
Highly Effective Methods (Failure Rate 1-6%)
- DMPA injection (Depo-Provera): 6% 1
Moderately Effective Methods (Failure Rate 9%)
Less Effective Methods (Failure Rate >12%)
- Male condom: 18% 1
- Female condom: 21% 1
- Withdrawal: 22% 1
- Fertility awareness methods: 24% 1
- Spermicides: 28% 1
Why Long-Acting Reversible Contraception (LARC) Dominates
The dramatic superiority of implants and IUDs stems from their user-independence—they require no daily adherence, no coital awareness, and no regular resupply. 1 This eliminates the primary cause of contraceptive failure: human error in consistent use.
Key Clinical Advantages of the Implant
- Effectiveness remains <1% even in overweight and obese women, with no decrease in efficacy by body mass index 2
- 84% continuation rate at one year, the highest of all reversible methods 1
- Provides 3 years of continuous protection without any user action required 1
- Rapid return to fertility after removal 3
Counseling Algorithm for Method Selection
Pediatricians and clinicians are explicitly encouraged to counsel patients starting with the most effective methods first—discussing LARC methods (implants and IUDs) before moving to less effective options. 1
Step 1: Present LARC Methods First
- Lead with the single-rod implant (0.05% failure rate) 1
- Follow with levonorgestrel IUD (0.2% failure rate) 1
- Emphasize that these methods are appropriate for nulliparous adolescents and do not cause infertility 3
Step 2: Address Specific Concerns
- For patients concerned about irregular bleeding: Counsel that this is the most common reason for implant discontinuation, but bleeding changes do not indicate contraceptive failure 1
- For patients with estrogen contraindications: Both implants and levonorgestrel IUDs are progestin-only and safe alternatives 1, 3
- For patients needing menstrual suppression: Levonorgestrel IUDs provide therapeutic benefits for heavy bleeding and dysmenorrhoria 3
Step 3: Discuss Shorter-Acting Methods Only If LARC Declined
- Combined hormonal methods (pills, patch, ring) all have 9% typical-use failure rates 1
- DMPA injection has 6% failure rate but only 56% continuation at one year 1
Critical Pitfalls to Avoid
Do not recommend barrier methods or traditional methods to patients who cannot accept pregnancy risk. 1 Withdrawal (22% failure rate) and condoms (18% failure rate for males) are "unforgiving of incorrect use" and have substantially higher failure rates than LARC methods. 1
Do not assume that "perfect use" failure rates reflect real-world outcomes. 1 Typical-use rates account for missed pills, inconsistent condom use, and other adherence failures that occur in actual practice—this is what patients will experience.
Do not overlook the implant in favor of IUDs based solely on familiarity. While both are excellent, the implant has the single lowest failure rate (0.05% vs 0.2% for levonorgestrel IUD), requires no pelvic exam for insertion, and can be placed immediately postpartum before hospital discharge. 1
Evidence Quality Note
These recommendations are based on high-quality guideline evidence from the American Academy of Pediatrics (2014) 1 and CDC Medical Eligibility Criteria (2010) 1, supplemented by recent research confirming implant effectiveness across all body weights 2 and updated typical-use failure rates from national survey data 4, 5.